Research using autologous cord blood — time for a policy change

Michael X Han and Maria E Craig
Med J Aust 2013; 199 (4): 288-299. || doi: 10.5694/mja12.10835
  • Michael X Han1
  • Maria E Craig2

  • 1 School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW.
  • 2 Institute of Endocrinology and Diabetes, Children’s Hospital at Westmead, Sydney, NSW.


Competing interests:

No relevant disclosures.

  • 1. Petrini C. Umbilical cord blood collection, storage and use: ethical issues. Blood Transfus 2010; 8: 139-148.
  • 2. Gallagher MP, Goland RS, Greenbaum CJ. Making progress: preserving beta cells in type 1 diabetes. Ann N Y Acad Sci 2011; 1243: 119-134.
  • 3. Akerblom HK, Krischer J, Virtanen SM, et al; The TRIGR Study Group. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up. Diabetologia 2011; 54: 627-633.
  • 4. Craig ME, Twigg SM, Donaghue KC, et al; Australian Type 1 Diabetes Guidelines Expert Advisory Group. National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Canberra: Australian Government Department of Health and Ageing, 2011.
  • 5. Stop Diabetes Australia. Type 1 Diabetes Prevention Trial. http://www. (accessed Jun 2013).
  • 6. Battaglia M, Roncarolo MG. Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes. Semin Immunol 2011; 23: 182-194.
  • 7. Mayer E, Bannert C, Gruber S, et al. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter. PLOS One 2012; 7: e29355.
  • 8. Rao M, Ahrlund-Richter L, Kaufman DS. Concise review: cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities. Stem Cells 2012; 30: 55-60.
  • 9. Haller MJ, Wasserfall CH, Hulme MA, et al. Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care 2011; 34: 2567-2569.
  • 10. Zhao Y, Jiang Z, Zhao T, et al. Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med 2012; 10: 3.
  • 11. Rosenau EH, Sugrue MW, Haller M, et al. Characteristics of thawed autologous umbilical cord blood. Transfusion 2012; 52: 2234-2242.
  • 12. Mayani H. Umbilical cord blood: lessons learned and lingering challenges after more than 20 years of basic and clinical research. Arch Med Res 2011; 42: 645-651.
  • 13. Rosenthal J, Woolfrey AE, Pawlowska A, et al. Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: an opportunity to revisit the controversy regarding cord blood banking for private use. Pediatr Blood Cancer 2011; 56: 1009-1012.
  • 14. Jensen A, Hamelmann E. First autologous cell therapy of cerebral palsy caused by hypoxic-ischemic brain damage in a child after cardiac arrest-individual treatment with cord blood. Case Rep Transplant 2013; 2013: 951827. doi: 10.1155/2013/951827.
  • 15. Wang F, Maeda N, Yasuhara T, et al. The therapeutic potential of human umbilical cord blood transplantation for neonatal hypoxic-ischemic brain injury and ischemic stroke. Acta Med Okayama 2012; 66: 429-434.
  • 16. US National Institutes of Health. (accessed Aug 2013).
  • 17. Sugarman J, Kaalund V, Kodish E, et al. Ethical issues in umbilical cord blood banking. JAMA 1997; 278: 938-943.
  • 18. Burgio GR, Gluckman E, Locatelli F. Ethical reappraisal of 15 years of cord-blood transplantation. Lancet 2003; 361: 250-252.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.